Atara Biotherapeutics, Inc. (ATRA) has provided a regulatory update following a recent Type A meeting with the U.S. FDA to discuss the Complete Response Letter issued for the Biologics License Application (BLA) for Tabelecleucel (tab-cel), which is being developed in partnership with Pierre Fabre Pharmaceuticals (PFP).
The shares of Cross Country Healthcare, Inc. (CCRN), a technology-driven healthcare workforce solutions company, were surging by more than 28% after the company announced it had entered into a definitive agreement to be acquired by Knox Lane, an investment firm. Under the terms of the agreement, Knox...
Halozyme Therapeutics, Inc. (HALO) has inked a global collaboration and license agreement with GSK plc (GSK) to develop subcutaneous formulations of multiple promising oncology targets.
Pharming Group N.V. (PHAR) will deliver multiple scientific presentations at the Clinical Immunology Society (CIS) 2026 Annual Meeting, taking place May 6-9, 2026, in New Orleans
Pharming Group N.V. (PHAR) reported its first-quarter 2026 financial results, showing lower total revenue year over year but strong growth from Joenja (Ieniolisib), alongside continued regulatory and clinical progress across its rare-disease portfolio.
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.